– Celadon Partners to acquire Senti’s manufacturing facility and CMC capabilities to establish GeneFab, an…
Phase 2a data published in The Lancet’s eBioMedicine supports further development of UB-311 The paper…
Phase 2a data published in The Lancet’s eBioMedicine supports further development of UB-311 The paper…
HOOKIPA reported positive preliminary Phase 2 data on HB-200 in combination with pembrolizumab in 1st-line…
HOOKIPA reported positive preliminary Phase 2 data on HB-200 in combination with pembrolizumab in 1st-line…
Ninth patient dosed in ongoing Phase 1b trial evaluating tegoprubart in patients undergoing kidney transplantation;…
Ninth patient dosed in ongoing Phase 1b trial evaluating tegoprubart in patients undergoing kidney transplantation;…
Camsirubicin Phase 1b Trial Currently at 5th Dose-Level (650 mg/m2), Generating Encouraging ResultsMNPR-101 Radiopharma Program…
Camsirubicin Phase 1b Trial Currently at 5th Dose-Level (650 mg/m2), Generating Encouraging ResultsMNPR-101 Radiopharma Program…
88% of all aflibercept 8 mg patients were on a ≥12-week dosing interval at the…
88% of all aflibercept 8 mg patients were on a ≥12-week dosing interval at the…
Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm…
Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm…
– Dutch Ministry of Health Approves VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce the Risk of…
Initiation of Phase 2b BEACON-IPF trial of bexotegrast in patients with IPF INTEGRIS-PSC Phase 2a…
NEWS RELEASE9 AUGUST 2023, 4PM ET / 22:00 CET Cigna Expands Commercial and…
The global modern card issuer had $54 billion in total processing volume, up 33 percent…
Highest Service Revenue Quarter To Date First Quarter of Adjusted EBITDA Profitability Raises Previously Announced…
– Second quarter revenue of $12.4M, +53% year-over-year growth– Second quarter pulse recurring revenue of…
– Second quarter revenue of $12.4M, +53% year-over-year growth– Second quarter pulse recurring revenue of…